Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1991 1
2005 1
2008 1
2015 2
2016 3
2017 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Diacylglycerol kinases in cancer.
Mérida I, Torres-Ayuso P, Ávila-Flores A, Arranz-Nicolás J, Andrada E, Tello-Lafoz M, Liébana R, Arcos R. Mérida I, et al. Among authors: arcos r. Adv Biol Regul. 2017 Jan;63:22-31. doi: 10.1016/j.jbior.2016.09.005. Epub 2016 Sep 23. Adv Biol Regul. 2017. PMID: 27697466 Review.
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer.
Patnaik A, Haluska P, Tolcher AW, Erlichman C, Papadopoulos KP, Lensing JL, Beeram M, Molina JR, Rasco DW, Arcos RR, Kelly CS, Wijayawardana SR, Zhang X, Stancato LF, Bell R, Shi P, Kulanthaivel P, Pitou C, Mulle LB, Farrington DL, Chan EM, Goetz MP. Patnaik A, et al. Among authors: arcos rr. Clin Cancer Res. 2016 Mar 1;22(5):1095-102. doi: 10.1158/1078-0432.CCR-15-1718. Epub 2015 Nov 18. Clin Cancer Res. 2016. PMID: 26581242 Free article. Clinical Trial.
[A case of right intraventricular tumor].
Azanza G, Arcos R, Quijano G, Villacís E, Maldonado J. Azanza G, et al. Among authors: arcos r. Arch Inst Cardiol Mex. 1969 May-Jun;39(3):409-14. Arch Inst Cardiol Mex. 1969. PMID: 5821358 Spanish. No abstract available.